Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024

SELL
$10.58 - $17.9 $49.9 Million - $84.4 Million
-4,712,552 Reduced 99.17%
39,645 $430,000
Q1 2024

May 15, 2024

BUY
$18.62 - $26.95 $88.5 Million - $128 Million
4,752,197 New
4,752,197 $89.1 Million
Q4 2023

Feb 12, 2024

BUY
$17.1 - $22.26 $104 Million - $135 Million
6,061,996 New
6,061,996 $131 Million
Q3 2023

Nov 14, 2023

BUY
$16.75 - $48.98 $3.49 Million - $10.2 Million
208,630 Added 3.28%
6,572,260 $135 Million
Q2 2023

Aug 14, 2023

BUY
$40.65 - $59.54 $26.4 Million - $38.7 Million
649,207 Added 11.36%
6,363,630 $299 Million
Q1 2023

May 12, 2023

BUY
$37.27 - $46.57 $7.39 Million - $9.23 Million
198,287 Added 3.59%
5,714,423 $240 Million
Q4 2022

Feb 13, 2023

BUY
$32.2 - $43.61 $18.8 Million - $25.5 Million
583,618 Added 11.83%
5,516,136 $210 Million
Q3 2022

Nov 14, 2022

BUY
$32.28 - $43.27 $5.9 Million - $7.91 Million
182,895 Added 3.85%
4,932,518 $193 Million
Q2 2022

Aug 15, 2022

SELL
$27.52 - $37.99 $61.8 Million - $85.3 Million
-2,245,377 Reduced 32.1%
4,749,623 $153 Million
Q1 2022

May 16, 2022

SELL
$30.71 - $45.71 $4.04 Million - $6.01 Million
-131,411 Reduced 1.84%
6,995,000 $232 Million
Q4 2021

Feb 11, 2022

BUY
$37.06 - $47.11 $13.2 Million - $16.8 Million
356,478 Added 5.27%
7,126,411 $303 Million
Q3 2021

Nov 15, 2021

BUY
$40.26 - $57.37 $38.6 Million - $55 Million
957,993 Added 16.48%
6,769,933 $300 Million
Q2 2021

Aug 16, 2021

BUY
$54.88 - $79.29 $35.5 Million - $51.2 Million
646,151 Added 12.51%
5,811,940 $330 Million
Q1 2021

May 17, 2021

BUY
$70.65 - $96.76 $62.3 Million - $85.4 Million
882,160 Added 20.59%
5,165,789 $387 Million
Q4 2020

Feb 12, 2021

BUY
$58.41 - $89.06 $236 Million - $360 Million
4,045,121 Added 1696.01%
4,283,629 $371 Million
Q3 2020

Nov 16, 2020

BUY
$41.13 - $62.45 $3.87 Million - $5.88 Million
94,161 Added 65.23%
238,508 $14.6 Million
Q2 2020

Aug 14, 2020

BUY
$25.95 - $43.15 $3.75 Million - $6.23 Million
144,347 New
144,347 $6 Million
Q1 2020

May 14, 2020

SELL
$26.15 - $77.24 $25.5 Million - $75.4 Million
-975,613 Closed
0 $0
Q4 2019

Feb 11, 2020

BUY
$60.18 - $154.77 $58.7 Million - $151 Million
975,613 New
975,613 $70.4 Million

Others Institutions Holding SAGE

About Sage Therapeutics, Inc.


  • Ticker SAGE
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 59,422,300
  • Market Cap $326M
  • Description
  • Sage Therapeutics, Inc., a biopharmaceutical company, develops and commercializes medicines to treat central nervous system disorders. Its lead product candidate is ZULRESSO, an intravenous formulation of brexanolone for the treatment of postpartum depression (PPD) in adults. The company's product pipeline also includes zuranolone, a neuroactive...
More about SAGE
Track This Portfolio

Track Wellington Management Group LLP Portfolio

Follow Wellington Management Group LLP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Wellington Management Group LLP, based on Form 13F filings with the SEC.

News

Stay updated on Wellington Management Group LLP with notifications on news.